July 2025 in “Journal of Clinical Research and Reports” This abstract provides a narrative overview of polycystic ovary syndrome, discussing its symptoms and related health issues, and does not include new research findings.
May 2023 in “International Journal of Home Science” This survey reported that 95% of respondents were aware of polycystic ovary syndrome, highlighting a high level of awareness about PCOS among the participants.
April 2018 in “Pharmaceutical and biological evaluations” This review discusses polycystic ovarian syndrome, highlighting its symptoms, potential causes, and treatment options, but reports no new clinical results.
2 citations
,
February 2022 in “Pakistan Armed Forces Medical Journal” This study found that women with PCOS reported significant appearance-related distress and social anxiety, especially in social settings.
7 citations
,
June 2015 in “EMBO Reports” This article discusses how DNA-based phenotyping is used by police to create visual profiles of suspects from crime scene samples, but reports no new research findings.
21 citations
,
March 2023 in “Indian Journal of Clinical Biochemistry”
This review outlines acne management strategies for individuals with polycystic ovary syndrome, but reports no new clinical results.
September 2025 in “Anti-Aging Eastern Europe” This review discusses the full spectrum of polycystic ovary syndrome's impact on women, highlighting the need for more comprehensive care that addresses both visible symptoms and hidden systemic burdens, and reports no new clinical results.
131 citations
,
August 2004 in “Best Practice & Research in Clinical Obstetrics & Gynaecology” This article reviews the complex pathophysiology of polycystic ovary syndrome, highlighting how genetic, hormonal, and environmental factors contribute to its diverse symptoms, and reports no new results.
January 2014 in “Healthy aging research” This review discusses the symptoms, diagnosis, and management of polycystic ovarian disease, emphasizing the complex implications of obesity and insulin resistance, and calls for long-term follow-up to assess management strategies.
2 citations
,
January 1970 in “Asian journal of pharmaceutical research and development” This review discusses the varying prevalence, symptoms, and potential genetic factors associated with Polycystic Ovary Syndrome in different populations, including its significant health impacts, and reports no new data on India's prevalence.
May 2024 in “Journal of the Egyptian Womenʼs Dermatologic Society” This study suggests that DPCP treatment can be effective and safe for severe alopecia areata in children, with maintenance therapy potentially reducing relapse rates.
This study found that CPA-loaded nanoparticles, particularly SLN formulations, increased CPA epidermal penetration compared to a conventional cream and may reduce side effects in treating androgen-dependent conditions.
4 citations
,
January 2024 in “Allergy” This study indicates that individuals exposed to PPD mount varying immune responses, with either tolerance, subclinical inflammation, or allergy, suggesting no true non-responders to PPD.
June 2024 in “Research Square (Research Square)” This study found that among young women in West Bengal, India, co-occurring PCOS and related conditions like estrogen resistance and leptin receptor insufficiency are common, with notable genetic variations identified, including impairments in leptin signaling and insulin resistance.
September 2016 in “Best Practice & Research in Clinical Obstetrics & Gynaecology” I'm sorry, but I can't provide a summary as I don't have the actual content of the document.
9 citations
,
December 2024 in “Clinical and Experimental Obstetrics & Gynecology” This review examines the impact of polycystic ovary syndrome on reproductive health, its pathophysiology, clinical manifestations, and emerging therapies, and reports no new findings; the authors emphasize the need for individualized treatment strategies.
May 2026 in “International Journal of Pharmaceutical Quality Assurance” This study reported that among 95 women with polycystic ovarian syndrome at a tertiary care hospital in India, menstrual irregularities were the most common issue, affecting 86.3% of participants, with many also experiencing hyperandrogenic symptoms, obesity, and infertility.
1 citations
,
July 2022 in “Zenodo (CERN European Organization for Nuclear Research)” This paper discusses the role of food and exercise in managing polycystic ovarian syndrome and reports no new results.
In this study, Paljeong-san pharmacopuncture reduced dihydrotestosterone levels and inhibited prostate tissue proliferation in a rat model of benign prostatic hyperplasia.
May 2026 in “International Journal of Advanced Biochemistry Research” In this case study, a three-year-old Labrador with canine atopic dermatitis showed significant improvement in pruritus and skin lesions after treatment with oclacitinib and supportive therapy over a one-month follow-up.
July 2025 in “International Journal of Ayurvedic Medicine” In this pilot study, Kantavallabha rasa, an Ayurvedic medicine, showed significant improvements in PCOS symptoms such as menstrual irregularities, pain, unwanted hair growth, skin issues, and ovarian conditions among 10 women with PCOS.
September 2024 in “Egyptian Journal of Health Care” This study found that after a planned teaching program, 95.38% of adolescent girls at Um Salama High School had an adequate level of knowledge about polycystic ovarian syndrome, indicating that education significantly improved their understanding of PCOS.
February 2020 in “Acta Scientific Women's Health” This narrative review discusses the various symptoms, diagnosis challenges, and treatment options for polycystic ovary syndrome, emphasizing the need for increased awareness and early diagnosis to prevent complications.
2 citations
,
June 2020 in “Journal of Applied Pharmaceutical Sciences and Research” This study reported an association between the rs6259 polymorphism affecting SHBG levels and PCOS in most Indian women, suggesting a potential genetic link in this population.
August 2020 in “Journal of Womens Health, Issues and Care” This review summarizes existing medications for Polycystic Ovary Syndrome, highlighting herbal treatments, but does not report new clinical results.
991 citations
,
January 2011 in “Nature Reviews Endocrinology” This paper reviews the diagnostic criteria, associated morbidities, and possible evolutionary advantages of polycystic ovary syndrome, but does not report any new findings.
13 citations
,
October 2024 in “Scientific Reports” In this study using data from young women in West Bengal, India, the researchers identified that leptin signaling impairment, insulin resistance, and specific gene mutations significantly contribute to PCOS, with obesity commonly manifesting in affected individuals.
January 2025 in “International Journal of Trichology” This study found that adding PRP to DPCP treatment for severe alopecia areata did not enhance effectiveness compared to DPCP alone.
September 2005 in “Morecambe Bay medical journal” This article discusses the complex condition of polycystic ovary syndrome and its modern management, emphasizing it as a multisystem disorder with significant impacts on patients' well-being.